Perspective Therapeutics, Inc. — Director's Dealing 2024

Dec 4, 2024

SEC Form 4/A — Form 4/A

Issuer: Perspective Therapeutics, Inc. (CATX)
CIK: 0000728387
Period of Report: 2024-11-25

Reporting Person: Spoor Johan M. (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	28257	Direct
Common Stock	5400	Indirect
Common Stock	12600	Indirect
Common Stock	1000	Indirect

Footnotes

F1: Beneficial ownership was reported to be 152,072 and should have been reported as 28,257.

F2: Indirect beneficial ownership was reported to be 66,600 and should have been reported as 12,600.

F3: Indirect beneficial ownership was reported to be 10,000 and should have been reported as 1,000.